{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:53:39Z","timestamp":1791687219975,"version":"4.3.4"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Information about national substance use trends among youths and adults after mid-March 2020 is limited due to constraints on surveillance during the COVID-19 pandemic.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate whether substance use prevalence in the early part of the pandemic (2020) differed from the prepandemic periods of 2018 to 2019 and 2016 to 2018.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study was a repeated analysis of 2016 to 2020 data from a nationally representative sample of youths and adults in the Population Assessment of Tobacco and Health (PATH) Study. Participants were representative of the US civilian noninstitutionalized population. Household residents age 13 years or older were interviewed in person from 2016 to 2019 and via telephone in 2020.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Age, calendar year.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Past 30-day self-reported use of any tobacco, any alcohol, binge drinking, cannabis, and any other illegal or misused prescription drugs.<\/jats:p><\/jats:sec>Results<\/jats:title>The overall nationally representative 2020 sample included 7129 youths (ages 13-17 years), 3628 young adults (ages 18-20 years), and 8874 adults (ages \u226521 years). Comparing 2018 to 2019 with 2020 among youths, prevalence of all substances used declined (eg, cannabis use declined in those aged 16-17 years from 14.9% to 7.6%; absolute difference, \u22127.3 percentage points [95% CI \u22128.8 to \u22125.8 percentage points]). Among young adults, prevalence of all substances other than any alcohol decreased significantly (eg, tobacco use declined from 37.8% to 22.8%; absolute difference, \u221215.1 percentage points [95% CI \u221216.8 to \u221213.3 percentage points]). In adults ages 21 to 24 years, any tobacco use declined from 39.0% to 30.9% (absolute difference, \u22128.2 percentage points [95% CI, \u221210.6 to \u22125.7 percentage points]), and alcohol use increased from 60.2% to 65.2% (absolute difference, 5.0 percentage points [95% CI, 2.3 to 7.7 percentage points]). Among adults aged 25 years or older, any tobacco use declined from 39.0% to 30.9% (absolute difference, \u22128.2 percentage points [95% CI, \u221210.6 to \u22125.7 percentage points]), cannabis use increased from 11.3% to 12.4% (absolute difference, 1.2 percentage points [95% CI, 0.3 to 2.0 percentage points]), and other substance use declined from 5.8% to 3.7% (absolute difference, \u22122.1 percentage points [95% CI, \u22122.9 to \u22121.4 percentage points]).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cross-sectional study, substance use decreased between 2019 and 2020 among those aged 13 to 20 years; consistent declines were not seen in older persons other than tobacco use reductions, and cannabis use increased among adults ages 25 years and older. While social changes during the COVID-19 pandemic could have affected substance use, findings should be interpreted with caution due to differences in data collection methods in 2016 to 2019 and 2020.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.54566","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:21:05Z","timestamp":1675182065000},"page":"e2254566","source":"Crossref","is-referenced-by-count":55,"title":["Tobacco, Alcohol, Cannabis, and Other Drug Use in the US Before and During the Early Phase of the COVID-19 Pandemic"],"prefix":"10.1001","volume":"6","author":[{"given":"Wilson M.","family":"Compton","sequence":"first","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry S. J.","family":"Flannagan","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"},{"name":"Kelly Government Solutions, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marushka L.","family":"Silveira","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"},{"name":"Kelly Government Solutions, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MeLisa R.","family":"Creamer","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Kimmel","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moana","family":"Kanel","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"},{"name":"Kelly Government Solutions, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Blanco","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"issue":"4","key":"zoi221542r4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/tobaccocontrol-2016-052934","article-title":"Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.","volume":"26","author":"Hyland","year":"2017","journal-title":"Tob Control"},{"issue":"1","key":"zoi221542r5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18001\/TRS.7.1.1","article-title":"Longitudinal uses of the Population Assessment of Tobacco and Health Study.","volume":"7","author":"Piesse","year":"2021","journal-title":"Tob Regul Sci"},{"issue":"6","key":"zoi221542r6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/tobaccocontrol-2018-054561","article-title":"Population Assessment of Tobacco and Health (PATH) reliability and validity study: selected reliability and validity estimates.","volume":"28","author":"Tourangeau","year":"2019","journal-title":"Tob Control"},{"issue":"4","key":"zoi221542r7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMsa1607538","article-title":"Tobacco-product use by adults and youths in the United States in 2013 and 2014.","volume":"376","author":"Kasza","year":"2017","journal-title":"N Engl J Med"},{"issue":"31","key":"zoi221542r9","first-page":"1","article-title":"Pseudoreplication: further evaluation and applications of the balanced half-sample technique.","author":"McCarthy","year":"1969","journal-title":"Vital Health Stat 2"},{"issue":"3","key":"zoi221542r10","first-page":"223","article-title":"Fay\u2019s method for variance estimation.","volume":"6","author":"Judkins","year":"1990","journal-title":"J Off Stat"},{"key":"zoi221542r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110171","article-title":"COVID-19 pandemic impact on children and adolescents\u2019 mental health: biological, environmental, and social factors.","volume":"106","author":"de Figueiredo","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"zoi221542r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108822","article-title":"Adolescent drug use before and during U.S. national COVID-19 social distancing policies.","volume":"226","author":"Miech","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"32","key":"zoi221542r14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic\u2014United States.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi221542r15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/add.v116.5","article-title":"The impact of survey mode on US national estimates of adolescent drug prevalence: results from a randomized controlled study.","volume":"116","author":"Miech","year":"2021","journal-title":"Addiction"},{"issue":"6","key":"zoi221542r16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.15288\/jsad.2020.81.725","article-title":"Changes in alcohol consumption among college students due to COVID-19: effects of campus closure and residential change.","volume":"81","author":"White","year":"2020","journal-title":"J Stud Alcohol Drugs"},{"key":"zoi221542r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.008","article-title":"Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.","volume":"204","author":"Compton","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi221542r18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s42238-020-00051-z","article-title":"The effectiveness of inhaled cannabis flower for the treatment of agitation\/irritability, anxiety, and common stress.","volume":"2","author":"Stith","year":"2020","journal-title":"J Cannabis Res"},{"issue":"11","key":"zoi221542r19","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamapediatrics.2021.2482","article-title":"Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis.","volume":"175","author":"Racine","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"6","key":"zoi221542r20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1513\/AnnalsATS.202110-1184RL","article-title":"Smoking prevalence during the COVID-19 pandemic in the United States.","volume":"19","author":"Gaffney","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"zoi221542r21","doi-asserted-by":"publisher","first-page":"17846","DOI":"10.1038\/s41598-022-22686-z","article-title":"Anxiety in the adult population from the onset to termination of social distancing protocols during the COVID-19: a 20-month longitudinal study.","volume":"12","author":"Hoffart","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"zoi221542r23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1176\/appi.ajp.2009.09081087","article-title":"The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States.","volume":"167","author":"Compton","year":"2010","journal-title":"Am J Psychiatry"},{"key":"zoi221542r24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.socscimed.2015.04.028","article-title":"Gender, coping strategies, homelessness stressors, and income generation among homeless young adults in three cities.","volume":"135","author":"Ferguson","year":"2015","journal-title":"Soc Sci Med"},{"key":"zoi221542r1","volume-title":"Monitoring the Future National Survey Results on Drug Use, 1975-2020: Secondary School Students","author":"Miech","year":"2021"},{"key":"zoi221542r8","article-title":"Population Assessment of Tobacco and Health (PATH) Study Series.","author":"United States Department of Health and Human Services; National Institutes of Health; National Institute on Drug Abuse; Food and Drug Administration; Center for Tobacco Products"},{"key":"zoi221542r2","unstructured":"Center for Behavioral Health Statistics and Quality. 2020 NSDUH detailed tables. Accessed December 5, 2022. https:\/\/www.samhsa.gov\/data\/report\/2020-nsduh-detailed-tables"},{"key":"zoi221542r3","unstructured":"US Centers for Disease Control and Prevention. Youth Risk Behavior Survey. Accessed December 5, 2022. https:\/\/www.cdc.gov\/healthyyouth\/data\/yrbs\/index.htm"},{"key":"zoi221542r11","doi-asserted-by":"crossref","unstructured":"Klein? RJ, Proctor? SE, Boudreault? MA, Turczyn? KM. Healthy People 2010 criteria for data suppression.? Stat Notes. 2002;24:1-12. Accessed December 29, 2022. https:\/\/www.cdc.gov\/nchs\/data\/statnt\/statnt24.pdf","DOI":"10.1037\/e583742012-001"},{"key":"zoi221542r22","unstructured":"Miech? RA, Schulenberg? JE, Johnston? LD, Bachman? JG, O\u2019Malley? PM, Patrick? ME. Teen use of illicit drugs decreased in 2021, as the COVID-19 pandemic continued. University of Michigan News Service. December 15, 2021. Accessed January 17, 2022. https:\/\/news.umich.edu\/teen-use-of-illicit-drugs-decreased-in-2021-as-the-covid-19-pandemic-continued\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2800843\/compton_2023_oi_221542_1674149740.91226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:21:15Z","timestamp":1675182075000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2800843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54566","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}